.svg){kind=small}
.svg){kind=logo}
Driving innovation
in clinical research
.png)
At the forefront of drug evolution
Leading the way in First-in-Human studies with a variety of patient populations.
Take your asset from First-in-Human to Proof of Concept in under one year with our specialist services.
Take your asset from First-in-Human to Proof of Concept in under one year with our specialist services.
Thorough QT Studies
.svg)
Take your asset from FIH to POC in under one year using our specialist services.
-min.jpg)
We are Richmond Pharmacology.
We are committed to advancing science and driving innovations in drug development.
We reduce drug development timelines using knowledge and expertise accumulated from over 500 clinical trials.
We reduce drug development timelines using knowledge and expertise accumulated from over 500 clinical trials.
Centre of excellence.
Richmond Pharmacology is a centre for excellence for First-In-Human and early phase clinical studies. We reduce drug development timelines using our Adaptive Protocols and efficient Patient Recruitment.
Our sponsors are granted fast international marketing approvals due to our inclusive study design which fulfils the data requirements of global regulators.
Our sponsors are granted fast international marketing approvals due to our inclusive study design which fulfils the data requirements of global regulators.
Work with us
We work with leading genetic engineering organisations, top 10 pharma companies and dynamic biotechs to assess the safety and efficacy of new therapeutics.
By working with us, you will gain a research partner who can expedite your study start up, enable fast decisions and reduce your drug development timelines.
-min.jpg)
.jpg)
Latest news
Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects
December 4, 2023
Groundbreaking research paper authored by Dr. Georg Ferber, Dr. Dilshat Djumanov, Dr. Ulrike Lorch, Dr. Edward Jackson, Dr. Joao Almeida Melo, Mr. James Rickard, and Dr. Jorg Taubel.
Read moreRichmond Pharmacology becomes Richmond in Brand Refresh
December 1, 2023
Refreshed brand reflects company’s growth over 22 years and renewed commitment to turning hope into reality for patients.
Read moreEvents
The 44th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)
14 – 16 December 2023
We are thrilled to share our participation in the 44th Annual Meeting of the Japan Society of Clinical Pharmacology.
View event
